nervive003008.jpg
nervive003007.jpg
wwb_img3.jpg
Effect of the VitalFlow on cerebral arteries (normal sheep angiography, below) and on brain perfusion (rabbit embolic stroke model; right).
Stroke
 
Number 1 cause of severe disability worldwide
Number 2 cause of death worldwide
16.9 million cases annually, 5.7 million will prove fatal
Increasing incidence and burden throughout the foreseeable future
Brain ischemia underlies 85% of all stroke ("ischemic stroke")
Hemorrhagic strokes may provoke cerebral artery constriction ("vasospasm")
 
Traumatic Brain Injury
 
60 million cases annually with 3.6 million cases being moderate or severe
$406 billion in healthcare and lost productivity costs in the U.S. alone
Expected to become the third most costly medical condition by 2020
Brain ischemia occurs acutely, often in combination with intracranial hemorrhage and seizures
Cerebral artery vasospasm ay also occur in a delayed fashion after TBI
 
About Brain Ischemia
a new treatment for brain ischemia
nervive003006.gif
About the VitalFlow Stimulator
nervive003005.gif
About Nervive
nervive003004.gif
Contact
nervive003003.gif
About the Management Team
nervive003002.gif
About Brain Ischemia
nervive003001.gif
VitalFlow Scientific Background